Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 27 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/1/2007 First Published: 4/1/1994


1.		Phase III Randomized Study of Radiotherapy With or Without Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus ABVD Only in Patients With Stage I-IIA Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				Other				CAN-NCIC-HD6 E-JHD06, NCI-V94-0427, NCT00002561, HD6, JHD06


2.		Phase III Pilot Study of Alternating Courses of MOPP and ABDV plus Radiotherapy with or without Levamisole for Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified								MSKCC-75104

Last Modified: 9/28/2006 First Published: 8/1/1998


3.		Phase III Randomized Study of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine (ABVD) Versus Doxorubicin, Vinblastine, Vincristine, Bleomycin, Mechlorethamine, Etoposide, and Prednisone (Stanford V) With or Without Radiotherapy in Patients With Locally Extensive or Advanced Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				16 and over				NCI				ECOG-2496 CAN-NCIC-HD7, CALGB-59905, SWOG-E2496, E2496, NCT00003389, HD7

Last Modified: 5/21/2007 First Published: 9/1/1998


4.		Phase III Randomized Study of a Four-Drug Anthracycline-Based Regimen or a Seven-Drug Hybrid or Eight-Drug Alternating Regimen in Patients With Advanced Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				Not specified								MRC-UKLG-LY09 EU-98020, NCT00003421

Last Modified: 6/12/2007 First Published: 4/1/2000


5.		Phase III Randomized Study of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine With or Without Autologous Peripheral Blood Stem Cell Transplantation and High-Dose Chemotherapy in Patients With Stage III or IV Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				15 to 65				NCI				SWOG-S9901 CLB-59802, E-S9901, NCT00005090, S9901

Last Modified: 12/1/1997


6.		Phase III Extended vs Involved Field Radiotherapy with or without MOPP Chemotherapy for Childhood Hodgkin's Disease (Summary Last Modified 12/97 km)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				under 18				NCI				CCG-541 CLB-7691, POG-7660


7.		Phase III Radiotherapy plus MOPP (NM/VCR/PCB/PRED) and ABVD (ADR/BLEO/VBL/DTIC) for Stage I/II Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MDA-RT-8001

Last Modified: 1/25/2008


8.		Phase III Study of MOPP (NM/VCR/PCB/PRED) vs ABVD (ADR/BLEO/VBL/DTIC) vs Alternating MOPP and ABVD for Stage III/IV Hodgkin's Disease and for Selected Patients with Stage I/II Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				16 and over				NCI				CLB-8251 CALGB-8251


9.		Phase III Radiotherapy Alone or in Combination with MOPP (NM/VCR/PCB/PRED) or MLMOPP (MOPP plus MTX/CF) for Hodgkin's Disease

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								UCCRC-2121B NCI-V83-0124


10.		Phase III MOPP (NM/VCR/PCB/PRED) plus Radiotherapy and ABVD (ADR/BLEO/VBL/DTIC), CVPP (CTX/VBL/PCB/PRED), or AB-DIC (ADR/BLEO/DTIC/CCNU/PRED) Salvage Therapy for Stage III Hodgkin's Disease in Adults

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				18 and over								MDA-IM-8007 NCI-V86-0049

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute